Cholinergic giant migrating contractions in conscious mouse colon assessed by using a novel noninvasive solid-state manometry method: modulation by stressors.
There is a glaring lack of knowledge on mouse colonic motility in vivo, primarily due to unavailability of adequate recording methods. Using a noninvasive miniature catheter pressure transducer inserted into the distal colon, we assessed changes in colonic motility in conscious mice induced by various acute or chronic stressors and determined the neurotransmitters mediating these changes. Mice exposed to restraint stress (RS) for 60 min displayed distal colonic phasic contractions including high-amplitude giant migrating contractions (GMCs), which had peak amplitudes >25 mmHg and occurred at a rate of 15-25 h(-1) of which over 50% were aborally propagative. Responses during the first 20-min of RS were characterized by high-frequency and high-amplitude contractions that were correlated with defecation. RS-induced GMCs and fecal pellet output were blocked by atropine (0.5 mg/kg ip) or the corticotrophin releasing factor (CRF) receptor antagonist astressin-B (100 microg/kg ip). RS activated colonic myenteric neurons as shown by Fos immunoreactivity. In mice previously exposed to repeated RS (60 min/day, 14 days), or in transgenic mice that overexpress CRF, the duration of stimulation of phasic colonic contractions was significantly shorter (10 vs. 20 min). In contrast to RS, abdominal surgery abolished colonic contractions including GMCs. These findings provide the first evidence for the presence of frequent cholinergic-dependent GMCs in the distal colon of conscious mice and their modulation by acute and chronic stressors. Noninvasive colonic manometry opens new venues to investigate colonic motor function in genetically modified mice relevant to diseases that involve colonic motility alterations.
Gourcerol
G
G
CURE/Digestive Diseases Research Center and Center for Stress-Neurobiology, UCLA, VA Greater Los Angeles Healthcare System, CURE Bldg. 115, Rm. 118B, 11301 Wilshire Blvd., Los Angeles, CA 90073, USA.
Wang
L
L
Adelson
D W
DW
Larauche
M
M
Taché
Y
Y
Million
M
M
D000208:Acute Disease; D000818:Animals; D001285:Atropine / Q000494:pharmacology; D002799:Cholinergic Fibers / Q000187:drug effects / Q000378:metabolism*; D003106:Colon / Q000187:drug effects / Q000294:innervation* / Q000601:surgery; D003108:Colonic Diseases / Q000209:etiology / Q000503:physiopathology; D003346:Corticotropin-Releasing Hormone / Q000494:pharmacology; D003672:Defecation; D013505:Digestive System Surgical Procedures / Q000009:adverse effects; D004195:Disease Models, Animal; D004867:Equipment Design; D005769:Gastrointestinal Motility / Q000187:drug effects; D045823:Ileus / Q000209:etiology / Q000503:physiopathology; D008297:Male; D008365:Manometry / Q000295:instrumentation / Q000379:methods*; D051379:Mice; D008810:Mice, Inbred C57BL; D008822:Mice, Transgenic; D008904:Miniaturization; D018727:Muscarinic Antagonists / Q000494:pharmacology; D009197:Myenteric Plexus / Q000187:drug effects / Q000378:metabolism / Q000503:physiopathology*; D026602:Nitrergic Neurons / Q000378:metabolism; D010446:Peptide Fragments / Q000494:pharmacology; D016760:Proto-Oncogene Proteins c-fos / Q000378:metabolism; D051381:Rats; D018019:Receptors, Corticotropin-Releasing Hormone / Q000037:antagonists & inhibitors / Q000235:genetics / Q000378:metabolism*; D012149:Restraint, Physical / Q000009:adverse effects; D013315:Stress, Psychological / Q000209:etiology / Q000378:metabolism / Q000503:physiopathology*; D013997:Time Factors; D014160:Transducers, Pressure; D015854:Up-Regulation
D018727:Muscarinic Antagonists; D010446:Peptide Fragments; D016760:Proto-Oncogene Proteins c-fos; D018019:Receptors, Corticotropin-Releasing Hormone; C120841:astressin B; D001285:Atropine; D003346:Corticotropin-Releasing Hormone